HEADER HYDROLASE/HYDROLASE INHIBITOR 18-SEP-14 4RDD TITLE CO-CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A CEFSULODIN DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SHP2 CATALYTIC DOMAIN; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1D, PTP-1D, PROTEIN-TYROSINE COMPND 6 PHOSPHATASE 2C, PTP-2C, SH-PTP2, SHP-2, SHP2, SH-PTP3; COMPND 7 EC: 3.1.3.48; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN11, PTP2C, SHPTP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21A+ KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.Y.ZHANG,Z.H.YU,R.HE,R.Y.ZHANG REVDAT 2 16-DEC-15 4RDD 1 JRNL REVDAT 1 01-JUL-15 4RDD 0 JRNL AUTH R.HE,Z.H.YU,R.Y.ZHANG,L.WU,A.M.GUNAWAN,B.S.LANE,J.S.SHIM, JRNL AUTH 2 L.F.ZENG,Y.HE,L.CHEN,C.D.WELLS,J.O.LIU,Z.Y.ZHANG JRNL TITL EXPLORING THE EXISTING DRUG SPACE FOR NOVEL PTYR MIMETIC AND JRNL TITL 2 SHP2 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 6 782 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26191366 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00118 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 35592 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.201 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1781 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.8577 - 3.7630 0.97 2659 141 0.1575 0.1627 REMARK 3 2 3.7630 - 2.9875 0.99 2654 140 0.1544 0.1839 REMARK 3 3 2.9875 - 2.6100 0.99 2669 140 0.1764 0.2073 REMARK 3 4 2.6100 - 2.3715 1.00 2670 140 0.1728 0.2145 REMARK 3 5 2.3715 - 2.2015 1.00 2656 139 0.1649 0.1893 REMARK 3 6 2.2015 - 2.0717 1.00 2677 141 0.1666 0.1942 REMARK 3 7 2.0717 - 1.9680 0.99 2663 141 0.1745 0.1935 REMARK 3 8 1.9680 - 1.8823 0.99 2661 140 0.1840 0.2208 REMARK 3 9 1.8823 - 1.8099 0.99 2635 139 0.2019 0.2720 REMARK 3 10 1.8099 - 1.7474 0.99 2662 138 0.2240 0.2658 REMARK 3 11 1.7474 - 1.6928 0.96 2575 137 0.2331 0.2923 REMARK 3 12 1.6928 - 1.6444 0.94 2507 131 0.2677 0.2757 REMARK 3 13 1.6444 - 1.6011 0.81 2123 114 0.2940 0.3372 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.100 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2227 REMARK 3 ANGLE : 1.098 3012 REMARK 3 CHIRALITY : 0.046 321 REMARK 3 PLANARITY : 0.006 394 REMARK 3 DIHEDRAL : 14.185 844 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4RDD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-SEP-14. REMARK 100 THE RCSB ID CODE IS RCSB087205. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97910 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : 0.07700 REMARK 200 FOR THE DATA SET : 22.0650 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.66600 REMARK 200 R SYM FOR SHELL (I) : 0.66600 REMARK 200 FOR SHELL : 1.504 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 33 MM CITRIC ACID, 67 MM REMARK 280 BIS-TRIS PROPANE, PH 7.4, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.63700 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 529 REMARK 465 GLU A 530 REMARK 465 HIS A 531 REMARK 465 HIS A 532 REMARK 465 HIS A 533 REMARK 465 HIS A 534 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 313 CG CD OE1 OE2 REMARK 470 GLU A 315 CB CG CD OE1 OE2 REMARK 470 THR A 316 CB OG1 CG2 REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 ASN A 319 CB CG OD1 ND2 REMARK 470 ASN A 320 CG OD1 ND2 REMARK 470 SER A 321 CB OG REMARK 470 LYS A 322 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1041 O HOH A 1052 2.12 REMARK 500 NH1 ARG A 278 O GLY A 332 2.13 REMARK 500 O HOH A 1019 O HOH A 1032 2.13 REMARK 500 O HOH A 971 O HOH A 977 2.14 REMARK 500 O HOH A 953 O HOH A 1061 2.16 REMARK 500 O HOH A 718 O HOH A 905 2.17 REMARK 500 O HOH A 955 O HOH A 1059 2.18 REMARK 500 O HOH A 754 O HOH A 953 2.18 REMARK 500 O HOH A 928 O HOH A 977 2.18 REMARK 500 OE1 GLU A 348 O HOH A 844 2.18 REMARK 500 O HOH A 720 O HOH A 907 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 322 -137.32 -156.31 REMARK 500 CYS A 459 -123.16 -128.86 REMARK 500 ILE A 463 -42.75 -132.91 REMARK 500 VAL A 505 102.88 67.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 936 DISTANCE = 5.94 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 3LU A 600 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3LU A 600 REMARK 999 REMARK 999 SEQUENCE REMARK 999 Isoform 2 (identifier: Q06124-2). The sequence of this isoform REMARK 999 differs from the canonical sequence as follows: residues 408-411 REMARK 999 are missing. DBREF 4RDD A 262 528 UNP Q06124 PTN11_HUMAN 262 532 SEQADV 4RDD A UNP Q06124 GLN 408 SEE REMARK 999 SEQADV 4RDD A UNP Q06124 ALA 409 SEE REMARK 999 SEQADV 4RDD A UNP Q06124 LEU 410 SEE REMARK 999 SEQADV 4RDD A UNP Q06124 LEU 411 SEE REMARK 999 SEQADV 4RDD LEU A 529 UNP Q06124 EXPRESSION TAG SEQADV 4RDD GLU A 530 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 531 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 532 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 533 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 534 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 535 UNP Q06124 EXPRESSION TAG SEQADV 4RDD HIS A 536 UNP Q06124 EXPRESSION TAG SEQRES 1 A 275 LEU TYR SER ARG LYS GLU GLY GLN ARG GLN GLU ASN LYS SEQRES 2 A 275 ASN LYS ASN ARG TYR LYS ASN ILE LEU PRO PHE ASP HIS SEQRES 3 A 275 THR ARG VAL VAL LEU HIS ASP GLY ASP PRO ASN GLU PRO SEQRES 4 A 275 VAL SER ASP TYR ILE ASN ALA ASN ILE ILE MET PRO GLU SEQRES 5 A 275 PHE GLU THR LYS CYS ASN ASN SER LYS PRO LYS LYS SER SEQRES 6 A 275 TYR ILE ALA THR GLN GLY CYS LEU GLN ASN THR VAL ASN SEQRES 7 A 275 ASP PHE TRP ARG MET VAL PHE GLN GLU ASN SER ARG VAL SEQRES 8 A 275 ILE VAL MET THR THR LYS GLU VAL GLU ARG GLY LYS SER SEQRES 9 A 275 LYS CYS VAL LYS TYR TRP PRO ASP GLU TYR ALA LEU LYS SEQRES 10 A 275 GLU TYR GLY VAL MET ARG VAL ARG ASN VAL LYS GLU SER SEQRES 11 A 275 ALA ALA HIS ASP TYR THR LEU ARG GLU LEU LYS LEU SER SEQRES 12 A 275 LYS VAL GLY GLN GLY ASN THR GLU ARG THR VAL TRP GLN SEQRES 13 A 275 TYR HIS PHE ARG THR TRP PRO ASP HIS GLY VAL PRO SER SEQRES 14 A 275 ASP PRO GLY GLY VAL LEU ASP PHE LEU GLU GLU VAL HIS SEQRES 15 A 275 HIS LYS GLN GLU SER ILE MET ASP ALA GLY PRO VAL VAL SEQRES 16 A 275 VAL HIS CYS SER ALA GLY ILE GLY ARG THR GLY THR PHE SEQRES 17 A 275 ILE VAL ILE ASP ILE LEU ILE ASP ILE ILE ARG GLU LYS SEQRES 18 A 275 GLY VAL ASP CYS ASP ILE ASP VAL PRO LYS THR ILE GLN SEQRES 19 A 275 MET VAL ARG SER GLN ARG SER GLY MET VAL GLN THR GLU SEQRES 20 A 275 ALA GLN TYR ARG PHE ILE TYR MET ALA VAL GLN HIS TYR SEQRES 21 A 275 ILE GLU THR LEU GLN ARG ARG LEU GLU HIS HIS HIS HIS SEQRES 22 A 275 HIS HIS HET 3LU A 600 28 HETNAM 3LU 1-({(2R)-4-CARBOXY-2-[(R)-CARBOXY{[(2R)-2-PHENYL-2- HETNAM 2 3LU SULFOACETYL]AMINO}METHYL]-3,6-DIHYDRO-2H-1,3-THIAZIN- HETNAM 3 3LU 5-YL}METHYL)PYRIDINIUM HETSYN 3LU CEFSULODIN, BOUND FORM FORMUL 2 3LU C21 H22 N3 O8 S2 1+ FORMUL 3 HOH *368(H2 O) HELIX 1 1 ARG A 265 ARG A 270 1 6 HELIX 2 2 GLN A 271 ASN A 277 5 7 HELIX 3 3 LEU A 334 ASN A 336 5 3 HELIX 4 4 THR A 337 ASN A 349 1 13 HELIX 5 5 PRO A 432 ILE A 449 1 18 HELIX 6 6 ILE A 463 GLY A 483 1 21 HELIX 7 7 ASP A 489 SER A 499 1 11 HELIX 8 8 THR A 507 ARG A 527 1 21 SHEET 1 A 9 ARG A 289 VAL A 291 0 SHEET 2 A 9 TYR A 304 ILE A 310 -1 O ALA A 307 N VAL A 290 SHEET 3 A 9 TYR A 327 THR A 330 -1 O TYR A 327 N ILE A 310 SHEET 4 A 9 VAL A 455 HIS A 458 1 O VAL A 457 N ILE A 328 SHEET 5 A 9 VAL A 352 MET A 355 1 N VAL A 354 O VAL A 456 SHEET 6 A 9 ARG A 413 PHE A 420 1 O TYR A 418 N ILE A 353 SHEET 7 A 9 TYR A 396 LYS A 405 -1 N THR A 397 O HIS A 419 SHEET 8 A 9 MET A 383 ALA A 392 -1 N ARG A 384 O SER A 404 SHEET 9 A 9 LEU A 377 TYR A 380 -1 N TYR A 380 O MET A 383 SHEET 1 B 2 VAL A 360 GLU A 361 0 SHEET 2 B 2 LYS A 364 SER A 365 -1 O LYS A 364 N GLU A 361 LINK SG CYS A 318 C16 3LU A 600 1555 1455 1.82 CISPEP 1 SER A 321 LYS A 322 0 4.28 SITE 1 AC1 20 TYR A 279 ILE A 282 CYS A 318 CYS A 459 SITE 2 AC1 20 SER A 460 ALA A 461 ILE A 463 GLY A 464 SITE 3 AC1 20 ARG A 465 GLN A 506 THR A 507 GLN A 510 SITE 4 AC1 20 HOH A 711 HOH A 716 HOH A 726 HOH A 770 SITE 5 AC1 20 HOH A 776 HOH A 786 HOH A 801 HOH A1016 CRYST1 39.638 75.274 48.046 90.00 99.11 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025228 0.000000 0.004045 0.00000 SCALE2 0.000000 0.013285 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021079 0.00000